Description:
Contract manufacturing is becoming increasingly vital in the pharmaceutical industry, particularly in cell and gene therapy due to the high demand for these innovative products. Kalorama Information’s report, Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs), provides comprehensive insights into this dynamic market.
Report Highlights
- Biopharmaceutical Contract Manufacturing Market: In-depth analysis of the current landscape and future trends.
- Role: Examination of the critical role CMOs play in the biopharmaceutical industry.
- Services Offered: Detailed overview of the services provided by CMOs, from development to commercialization.
- Usage Drivers: Factors driving the increased use of CMOs in cell and gene therapy.
- Profiles of Companies, Key Players, and Competitors in the Market: Detailed profiles of leading companies in the CMO market.
- COVID-19’s Challenges and Opportunities for CMOs: Analysis of the impact of the pandemic on CMOs, including challenges and new opportunities.
- Global and Regional Market Overviews—U.S., Europe, and Other Nations: Comprehensive market overviews by region.
- New Developments and Advancing Technology: Insights into the latest technological advancements and their implications for CMOs.
- Development Pipeline: Overview of the development pipeline for cell and gene therapy products.
- Production Issues: Examination of common production challenges and strategies to overcome them.
- Cost: Analysis of cost structures and economic considerations in CMO services.
- Logistics: Insights into logistics and supply chain management for CMOs.
- Mergers and Acquisitions: Exploration of recent M&A activities and their impact on the market.
Company Profiles
Kalorama profiles a select group of companies that are representative of the market or handle a large volume, providing a thorough understanding of the competitive landscape.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Cell and Gene Therapy Market Summary, by Product Segment, 2015-2025 ($ millions)
| Year | Dermatology | Cardiovascular | Oncology | Ophthalmolog | Musculoskeletal | Other | Total |
| 2015 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2016 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2017 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2018 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2019 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2020 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2021 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2022 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2023 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2024 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| 2025 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| CAGR 2015-2020 |
XX% | XX% | XX% | XX% | XX% | XX% | XX% |
| CAGR 2015-2025 |
XX% | XX% | XX% | XX% | XX% | XX% | XX% |
| CAGR 2020-2025 |
XX% | XX% | XX% | XX% | XX% | XX% | XX% |
Source: Kalorama Information
